H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 11.1% of adults in San Jose have diagnosed diabetes — 0.9 points below the U.S. 12% figure. Census population 983,489. California Medicare wound biologics: Noridian Healthcare Solutions (JE). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed San Jose clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a San Jose storefront.
361 HCT/P Compliant Tissue Products in San Jose, CA for clinics & physicians. Exclusively 361 HCT/P compli… Compliance support & pricing — contact Hawk Medical.
Adult arthritis here is 16.5% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. CDC PLACES (2023, crude) estimates 11.1% of adults in San Jose have diagnosed diabetes — 0.9 points below the U.S. 12% figure. Together those PLACES numbers are why a city of 500k–1M still needs separate PRP and CTP protocols. 361 hctp compliant products inventory is national; utilization is JE-local.
National 361 HCT/P Compliant Tissue Products notes (how the product actually works)CDC PLACES (2023, crude) estimates 11.1% of adults in San Jose have diagnosed diabetes — 0.9 points below the U.S. 12% figure. Adult obesity in San Jose is 23.7% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 16.5% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: JE / Noridian Healthcare Solutions, sibling states HI, NV. California Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
We are not going to invent a San Jose warehouse or a five-star local review. What you get is 361 hctp compliant products from FDA-registered sources, lot paperwork, and someone who has run the same SOPs in clinic — Joe Bradley. The local numbers on this page are CDC PLACES and CMS JE, not marketing adjectives.
CDC PLACES (2023, crude prevalence) estimates 11.1% of adults — 0.9 points below the U.S. 12% figure. Obesity is 23.7%; arthritis is 16.5%. That is place-level BRFSS modeling, not a clinic census and not a San Jose trial.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a California compliance risk.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including California.
Body copy and schema dateModified follow a pinned content version date, not a daily timestamp. CDC and CMS figures are cited to the public reports named on the page. Recheck MAC LCDs before each utilization change — those move faster than a landing page.
If you operate in California and another MAC state, say it on the first call. JE will not port 1:1. We would rather split utilization than watch a sister clinic copy San Jose tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in San Jose, CA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for San Jose is JE geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for San Jose — 0.9 points below the U.S. 12% figure. Planning input, not an outcomes claim.
California Part B wound biologics follow this contractor (siblings: HI, NV). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in San Jose. Useful for joint-program math; still needs a diagnosis and privileging.
No San Jose storefront. Joe Bradley is an active practice owner. 361 hctp compliant products stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.